Application of gamma process to two-agent combinations with delayed toxicity

DOI10.1080/03610918.2018.1554107MaRDI QIDQ5083969zbMATH OpenOpenAlexFDO

Authors Shinjo Yada, Chikuma Hamada

Publication date 21 June 2022

Published in Communications in Statistics. Simulation and Computation (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/03610918.2018.1554107

zbMATH Keywords

missing datagamma processphase I clinical trialdata augmentation algorithmdelayed toxicity

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• A Bayesian dose-finding design for drug combination trials with delayed toxicities
• Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity
• A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology
• Dose-finding with two agents in phase I oncology trials
• Time-to-event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial

Cites work

• scientific article; zbMATH DE number 3602503 (Why is no real title available?)
• A Bayesian dose-finding design for drug combination trials with delayed toxicities
• A Bayesian nonparametric approach to reliability
• A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents
• Bayesian biostatistics
• Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity
• Bayesian designs for phase I--II clinical trials
• Robust EM continual reassessment method in oncology dose finding
• The Calculation of Posterior Distributions by Data Augmentation

Cited in

(1)

• Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity

This page was built for publication: Application of gamma process to two-agent combinations with delayed toxicity

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5083969)